Michael Slama

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    UCB
    Topic:
    Myasthenia gravis
    Date added:
    09/10/2026
    Date updated:
    09/10/2026
    Relationship end date:
    04/30/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Alexion
    Topic:
    Myasthenia gravis
    Date added:
    09/10/2026
    Date updated:
    09/10/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Argenx
    Topic:
    Myasthenia gravis and CIDP
    Date added:
    09/10/2026
    Date updated:
    09/10/2026
    Relationship end date:
    02/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Amgen
    Topic:
    Myasthenia gravis
    Date added:
    09/10/2026
    Date updated:
    09/10/2026
    Relationship end date:
    10/31/2025
Return to MDA Case Discussions: Navigating Diagnosis and Treatment Decisions in Myasthenia Gravis